Michael Parini

Michael Parini serves as Chief Executive Officer at Freeline Therapeutics GmbH. Freeline Therapeutics GmbH operates in the research sector with approximately 330.0 employees. The company is headquartered in New York, New York.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Salesforce Outlook NetSuite MailChimp SPF Zendesk Barracuda Networks Amazon SES Varnish Gravity Forms WordPress.org Nginx Google Tag Manager Mobile Friendly Vimeo Google Maps Google Font API Render Remote AI Viewpoint Basis

aav gene therapy life changing innovation purpose biotechnology gaucher parkinsons disease biotechnology: biological products (no diagnostic substances) health care biotechnology research clinical-stage biotech life-changing therapies transformational gene therapies gaucher disease parkinson's disease adrenomyeloneuropathy amn disease-modifying treatments chronic conditions genetic medicines biotech gene expression aav capsids therapeutic proteins mutated genes rare diseases chronic disease treatment in vivo therapy ex vivo therapy preclinical studies clinical trials therapeutic benefit protein production envelope-free viral vectors safety & efficacy fda compliance genetic material delivery personalized medicine regulatory approval one-time gene therapy infusion chronic condition management biopharma industry genetic medicine innovation healthcare collaboration affordable treatments transgene optimization immunogenicity reduction disease progression intervention transformative outcomes gene therapy pipeline leading chronic illness therapies therapeutic advancements clinical results optimization disease-targeting strategies treatment burden reduction genetic therapy education patient well-being improvement dementia cardiovascular diseases clinical-stage biotechnology innovative medicine genetic medicine transformative therapies neurological disorders patient-centric fda approval market potential healthcare professionals patient outcomes unmet medical needs genetic disorders therapeutic innovation pipeline development collaborative approach breakthrough treatments one-time therapies disease-modifying therapies chronic debilitating conditions optimized gene therapy patient engagement biotechnology partnerships health technology clinical research genetic engineering health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Michael Parini?

Michael Parini's verified email address is available on MessageCEO. They currently work at Freeline Therapeutics GmbH. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Michael Parini lead?

Michael Parini is Chief Executive Officer at Freeline Therapeutics GmbH, a company in the research sector with 330.0 employees. The company is based in New York, New York.

What industry is Michael Parini in?

Michael Parini works in the research industry as Chief Executive Officer at Freeline Therapeutics GmbH. MessageCEO provides verified contact information for executives across all major industries.

Is Michael Parini's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michael Parini's profile is kept up-to-date with the latest available information.

Last updated: April 7, 2026